Sands Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,722,467
Closed -$241M 76
2018
Q4
$241M Sell
1,722,467
-122,363
-7% -$18.6M 0.86% 35
2018
Q3
$315M Sell
1,844,830
-163,407
-8% -$27.5M 0.89% 31
2018
Q2
$348M Sell
2,008,237
-121,236
-6% -$18.2M 1% 31
2018
Q1
$246M Sell
2,129,473
-142,636
-6% -$15.2M 0.73% 32
2017
Q4
$191M Buy
+2,272,109
New +$189M 0.58% 34

Other funds holding LOXO

Sands Capital Management's LOXO Position: Q1 2019 in Review

Sands Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,722,467 shares — an estimated $241M sold.

Sands Capital Management first reported a position in LOXO in Q4 2017 and held it in 5 quarters. The position peaked at $348M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Sands Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Sands Capital Management sold 1,722,467 Loxo Oncology, Inc shares in Q1 2019, an estimated $241M.
  • Sands Capital Management first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 5 quarters.
  • Sands Capital Management's Loxo Oncology, Inc position peaked at $348M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Sands Capital Management's 13F filing for Q1 2019, filed 15 May 2019.